A spin-off from astrophysics research, our patented, breakthrough monochromatic x-ray mammography instrument offers an unprecedented combination of sensitivity, spatial resolution, low-dose, and ease of use.
It promises to overcome many of the problems with the detection of cancerous lesions in dense breasts. This 2-D and 3-D diagnostic tool will serve a very large group of women (30-50%) who go undiagnosed and who are most at risk for developing breast cancer.
It will reduce screening doses by more than a factor of 20 for ALL women, allowing annual exams that substantially reduce lifetime radiation exposure.
Instruments incorporating this technology will cost no more to produce than units currently used in breast care clinics.